Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Opus Point Partners Management, LLC (CIK 1600175) reported $55.3M across 53 reported positions in its SEC 13F filing for 2019-09-30. Largest positions: IBB ($20.9M, 37.76%), LABU ($3.1M, 5.58%), MTD ($2.3M, 4.12%), BMY ($1.7M, 3.02%), SGEN ($1.5M, 2.78%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | IBB | ISHARES TR | $20.9M | 37.76% | 210,000 | Hold |
| 2 | LABU | DIREXION SHS ETF TR | $3.1M | 5.58% | 99,855 | Added |
| 3 | MTD | METTLER TOLEDO INTERNATIONAL | $2.3M | 4.12% | 3,235 | Hold |
| 4 | BMY | BRISTOL MYERS SQUIBB CO | $1.7M | 3.02% | 33,000 | Hold |
| 5 | SGEN | SEATTLE GENETICS INC | $1.5M | 2.78% | 18,020 | Added |
| 6 | ILMN | ILLUMINA INC | $1.4M | 2.59% | 4,721 | Added |
| 7 | VRTX | VERTEX PHARMACEUTICALS INC | $1.4M | 2.54% | 8,279 | Added |
| 8 | IONS | IONIS PHARMACEUTICALS INC | $1.2M | 2.18% | 20,124 | Hold |
| 9 | ALNY | ALNYLAM PHARMACEUTICALS INC | $1.1M | 1.99% | 13,684 | Added |
| 10 | ALXN | ALEXION PHARMACEUTICALS INC | $973,000 | 1.76% | 9,933 | Added |
| 11 | QGEN | QIAGEN NV | $951,000 | 1.72% | 28,858 | Hold |
| 12 | ONCE | SPARK THERAPEUTICS INC | $941,000 | 1.70% | 9,699 | Hold |
| 13 | FBIO | FORTRESS BIOTECH INC | $865,000 | 1.56% | 613,551 | Added |
| 14 | PRQR | PROQR THRAPEUTICS N V | $798,000 | 1.44% | 138,461 | Hold |
| 15 | INCY | INCYTE CORP | $791,000 | 1.43% | 10,659 | Added |
| 16 | EXAS | EXACT SCIENCES CORP | $771,000 | 1.39% | 8,534 | Hold |
| 17 | REGN | REGENERON PHARMACEUTICALS | $677,000 | 1.22% | 2,439 | Added |
| 18 | BMRN | BIOMARIN PHARMACEUTICAL INC | $654,000 | 1.18% | 9,700 | Added |
| 19 | DCPH | DECIPHERA PHARMACEUTICALS IN | $632,000 | 1.14% | 18,631 | Hold |
| 20 | ASND | ASCENDIS PHARMA A S | $596,000 | 1.08% | 6,190 | Hold |
| 21 | CELG | CELGENE CORP | $559,000 | 1.01% | 5,625 | Hold |
| 22 | QURE | UNIQURE NV | $560,000 | 1.01% | 14,215 | Hold |
| 23 | CRSP | CRISPR THERAPEUTICS AG | $542,000 | 0.98% | 13,214 | Hold |
| 24 | EPZM | EPIZYME INC | $520,000 | 0.94% | 50,378 | Hold |
| 25 | AMRN | AMARIN CORP PLC | $510,000 | 0.92% | 33,641 | Added |
Source: SEC Form 13F filings · as of 2019-09-30